CPT2 and breast carcinoma: A study by Sun et al. used MSI to demonstrate, for the first time, spatially resolved reprogramming of carnitine metabolism and altered expression of carnitine palmitoyl transferase 2 (CPT2) and carnitine acetyltransferase (CAT) in breast cancer [233].